The CAV2 Knockout Raji Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal population derived from the Raji human Burkitt lymphoma B lymphocyte line, with targeted gene disruption of caveolin-2 (CAV2). This heterogeneous knockout model lacks CAV2 protein expression, providing a powerful tool to investigate the scaffolding functions of CAV2 in caveolar biogenesis, endocytosis, lipid trafficking, and signal transduction. The polyclonal format ensures a broader representation of editing events compared to clonal lines, facilitating robust functional studies.
Raji cells are an Epstein-Barr virus (EBV)-positive Burkitt lymphoma line originating from a B lymphocyte lineage. They recapitulate key features of germinal center B cells, constitutively activate oncogenic pathways, and are extensively utilized for studying B cell receptor signaling, EBV-driven oncogenesis, and chemotherapeutic resistance mechanisms. This background is particularly relevant for exploring the roles of caveolar proteins in lymphoma biology and tumor microenvironment interactions.
Caveolin-2 is a membrane scaffolding protein that hetero-oligomerizes with caveolin-1 (CAV1) to form the structural core of caveolae. Through its scaffolding domain, CAV2 directly interacts with and modulates the activity of eNOS, Src family kinases, EGFR, and integrin ??1, thereby compartmentalizing and fine-tuning signaling cascades. This regulation impacts the MAPK/ERK, PI3K/AKT, and STAT3 pathways, while also governing cholesterol transport and lipid homeostasis. Transcriptionally, CAV2 is controlled by p53, NF-??B, and FoxO1, and its downstream effects include altered expression of cyclin D1 and p21, influencing cell cycle progression and survival.
In the context of Raji lymphoma, CAV2 disruption is critical because EBV latent membrane proteins exploit caveolar platforms to activate Src and PI3K/AKT signaling. Loss of CAV2 may redistribute these signals, altering proliferation, migration, and drug sensitivity, especially to anthracyclines like doxorubicin. Since Raji cells express CAV1, the knockout of its obligate partner can destabilize caveolar structures and disrupt lipid raft microdomains, offering a unique system to dissect caveolin-dependent and -independent functions in B cell transformation, EBV latency, and malignant progression.
These CAV2 knockout polyclonal cells enable detailed mechanistic studies using co-immunoprecipitation to assess interactions with CAV1 and cavin proteins, immunofluorescence to visualize caveolar integrity, and phospho-kinase arrays to profile signaling network adaptations. Functional assays including MTS proliferation, Annexin V apoptosis, and Transwell migration can quantify phenotypic consequences, while drug sensitivity testing with doxorubicin evaluates therapeutic vulnerabilities. The model also supports investigation of EBV-mediated activation of STAT3 and NF-??B. For technical assistance or custom inquiries, please contact Ascent Research.
